NasdaqGM:ARDXBiotechs
Assessing Ardelyx (ARDX) Valuation After Strong IBSRELA Growth And Upbeat 2026 Revenue Guidance
Ardelyx (ARDX) has released its full year 2025 results, reporting US$407.32 million in revenue and a net loss of US$61.6 million, along with detailed guidance for 2026.
See our latest analysis for Ardelyx.
Despite strong revenue growth from IBSRELA and fresh guidance for 2026, Ardelyx's 1 day share price return of a 14.99% decline and 1 month share price return of a 26.25% decline suggest momentum has cooled recently, even as the 3 year total shareholder return of 94.24% remains very...